Received Jun 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RAB | RABIES (IMOVAX) | SANOFI PASTEUR | 2 | — | OT / LA |
developed rashes around the injection site after the second dose,described the rash to be circular; Initial information received on 02-Jun-2025 regarding an unsolicited valid non-serious case received from other health professional. This case involves a 22 years old and unknown gender patient who had developed rashes around the injection site after the second dose,described the rash to be circular after receiving rabies (HDC) vaccine [Imovax rabies]. The patient's past medical history, medical treatment(s), concomitant medications, vaccination(s) and family history were not provided. On 23-May-2025, the patient received Dose 2 of 1 ml of suspect rabies (HDC) vaccine Powder and solvent for suspension for injection of strength standard and frequency once (Unknown lot and expiry date) via intramuscular route in the left arm for Immunisation. Information on the batch number was requested corresponding to the one at time of event occurrence. On 23-May-2025 the patient developed rashes around the injection site after the second dose, described the rash to be circular (vaccination site rash) (Latency same day). Reportedly, reporter reported that a patient developed rashes around the injection site after the second dose but eventually disappeared. the patient was not given any treatment. Action taken was not applicable. It was not reported if the patient received a corrective treatment for the event. At time of reporting, the outcome was Recovered / Resolved in May 2025 for the event.